Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Drexel University
With
The Center for Pediatric Pharmacotherapy
This investigation is intended to collect safety information for the technique of mixing cefazolin in the CRRT solution on the CRRT circuit, the patient, in addition to collecting information regarding the ability to obtain therapeutic cefazolin serum concentrations in addition to utilizing a dosing algorithm to adjust the cefazolin concentration in the CRRT solution.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients eligible to participate in the study must have a need for continuous renal replacement therapy (CRRT) of any modality:
1. History of any moderate or severe hypersensitivity or allergic reaction to cefazolin (a history of mild rash followed by uneventful re-exposure and/or red man syndrome is not a contraindication)
2. Any rapidly-progressing disease or immediately life-threatening illness (defined as imminent death within 48 hours in the opinion of the investigator)
3. Any condition or circumstance that, in the opinion of the investigator, would compromise the safety of the patient or the quality of study data